John Collinge
Founder at D-Gen Ltd.
John Collinge active positions
| Companies | Position | Start | End |
|---|---|---|---|
D-Gen Ltd.
 D-Gen Ltd. BiotechnologyHealth Technology D-Gen Ltd. develops technologies for detection and prevention of prion diseases. The firm offers services that include prion reduction studies, in-process validation and contract sample testing. The company was founded in by John Collinge on November 19, 1998 and is headquartered in London, the United Kingdom. | Director/Board Member | 1998-11-18 | - |
| Founder | 1998-11-18 | - | |
| University College London | Corporate Officer/Principal | - | - |
| The National Hospital for Neurology & Neurosurgery | Corporate Officer/Principal | - | - |
Career history of John Collinge
Former positions of John Collinge
| Companies | Position | Start | End |
|---|---|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - | - |
| Imperial College London | Corporate Officer/Principal | - | - |
Statistics
International
| United Kingdom | 6 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
D-Gen Ltd.
D-Gen Ltd. BiotechnologyHealth Technology D-Gen Ltd. develops technologies for detection and prevention of prion diseases. The firm offers services that include prion reduction studies, in-process validation and contract sample testing. The company was founded in by John Collinge on November 19, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| The National Hospital for Neurology & Neurosurgery |
- Stock Market
- Insiders
- John Collinge
- Experience
